Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Record history shows updates to Study Status and Recruitment Status across multiple versions, with changes to Contacts/Locations. These entries reflect ongoing monitoring of the trial’s progress and point of contact information.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:52.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Core content updated: new government funding and operating status notice plus a v3.2.0 release; previous v3.1.0 tag removed.
    Difference
    12%
    Check dated 2025-10-06T05:58:24.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:12:55.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.7%
    Check dated 2025-09-14T20:11:05.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-09-07T17:02:53.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    19%
    Check dated 2025-08-31T12:09:40.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.